Arcellx, Inc.

United States of America


Order your weekly watch
Total IP 37
Total IP Rank # 38,734
IP Activity Score 2.4/5.0    34
IP Activity Rank # 22,584
Stock Symbol ACLX (nasdaq)
ISIN US03940C1009
Market Cap. 4,600M  (USD)
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

16 2
7 1
7 0
4
 
Last Patent 2025 - D-domain containing polypeptides...
First Patent 2016 - De novo binding domain containin...
Last Trademark 2022 - ARCELLX
First Trademark 2017 - ARCELLX

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 Invention D-domain containing polypeptides and uses thereof. D domain (DD) containing polypeptides (DDpp) ...
2024 Invention Multifunctional immune cell therapies. Provided herein are multi-functional chimeric antigen rec...
2023 Invention D-domain containing polypeptides and uses thereof
Invention D-domain containing polypeptides and uses thereof. in vitroinvivo.vivo.
Invention D-domain containing polypeptides and uses thereof. Provided herein are D domain containing polype...
2022 G/S Biological preparations for the treatment of cancer using genetically engineered cells; pharmaceu...
Invention Multifunctional immune cell therapies. Provided herein are multi-functional chimeric antigen rece...
Invention Multifunctional immune cell therapies. in vitroin vivoin vivo. In some embodiments, the CAR cell ...
2021 Invention De novo binding domain containing polypeptides and uses thereof. Provided herein are de novo bind...
2020 Invention De novo binding domain containing polypeptides and uses thereof. Provided herein are de novo bin...
2018 Invention D-domain containing polypeptides and uses thereof. D domain (DD) containing polypeptides (DDpp) t...
Invention D-domain containing polypeptides and uses thereof. e.ge.g., BCMA, CD123, CS1, HER2, AFP, and AFP ...
2017 G/S Pharmaceutical preparations for targeting tissues based on select tissue markers and ligands for ...